Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis

被引:14
|
作者
Casellas, Francesc [1 ]
Vicens, Daniel Ginard [2 ]
Riestra Menendez, Sabino [3 ]
Alfaro Oliver, Noelia [4 ]
机构
[1] Hosp Univ Vall dHebron, Ciberehd, Crohn Colitis Care Unit, Barcelona 08035, Spain
[2] Hosp Univ Son Espases, Dept Gastroenterol, Palma de Mallorca 07120, Islas Baleares, Spain
[3] Hosp Univ Cent Asturias, Dept Gastroenterol, Oviedo 33006, Asturias, Spain
[4] Adv Res Tech Hlth Serv TAISS, Madrid 28034, Spain
关键词
Ulcerative colitis; Management of the disease; Treatment of the disease; Quality of life; Patient satisfaction; INFLAMMATORY-BOWEL-DISEASE; HEALTH-CARE; SATISFACTION; PERSPECTIVE; COPENHAGEN;
D O I
10.1016/j.crohns.2014.02.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To establish the perceptions, attitudes, experiences, and satisfaction with clinical management of ulcerative colitis (UC) patients, particularly in aspects related to treatment. Methods: A qualitative, descriptive, exploratory study. A discussion group was performed in patients who were in remission according to the criteria of the Mayo index, who had never taken biologics or corticosteroids in the past year. They were selected by: course (mild/moderate), time since onset (under 5 years/5 to 9 years/10 years or more), follow-up area (primary care [PC]-hospital/PC-specialist care/hospital), treatment (yes/no), UC care unit (yes/no), belongs to patient associations (yes/no) and sex. A descriptive-interpretative content analysis was performed to detect emerging categories, providing them with an explanatory framework. Results: Diagnostic delay was detected due to lack of clinical suspicion from PC and delayed diagnostic tests. For follow-up, patients prefer care on demand, channeled through remote care, which helps to resolve questions, problems with treatment, or when a relapse occurs, minimizing visits to the hospital. They demand more information, both about UC and treatment. The expectations about treatments are limited, so they mainly requested efficacy and safety. Conclusion: The results suggest the importance of developing strategies to facilitate care on demand and remote care, and to investigate on effective and safe treatments to minimize the detriment to quality of life of patients. These strategies should guarantee fast care and, together with safe and effective treatments, optimize the management of UC patients. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1097 / 1107
页数:11
相关论文
共 50 条
  • [1] Management of Mild-to-Moderate Ulcerative Colitis
    Siegmund, Britta
    DIGESTIVE DISEASES, 2015, 33 : 90 - 94
  • [2] Patient satisfaction in the management of mild-to-moderate ulcerative colitis: Results of a Delphi study among patients and physicians
    Casellas, Francesc
    Ginard, Daniel
    Riestra, Sabino
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1172 - 1179
  • [3] Practical management of mild-to-moderate ulcerative colitis: an international expert consensus
    D'Amico, Ferdinando
    Magro, Fernando
    Dignass, Axel
    Al Awadhi, Sameer
    Gutierrez Casbas, Ana
    Queiroz, Natalia Sousa Freitas
    Rydzewska, Grazyna
    Duk Ye, Byong
    Ran, Zhihua
    Hart, Ailsa
    Jairath, Vipul
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (08) : 421 - 430
  • [4] Management and treatment optimization of patients with mild to moderate ulcerative colitis
    D'Amico, Ferdinando
    Fasulo, Ernesto
    Jairath, Vipul
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 277 - 290
  • [5] AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
    Singh, Siddharth
    Feuerstein, Joseph D.
    Binion, David G.
    Tremaine, William J.
    GASTROENTEROLOGY, 2019, 156 (03) : 769 - +
  • [6] Drug Optimization in Patients with Mild-to-Moderate Ulcerative Colitis: A Global Survey
    D'Amico, Ferdinando
    Jairath, Vipul
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [7] Mesalazine granules promote disease clearance in patients with mild-to-moderate ulcerative colitis
    Kruis, Wolfgang
    Meszaros, Silke
    Wehrum, Sarah
    Mueller, Ralph
    Greinwald, Roland
    Nacak, Tanju
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (08) : 775 - 783
  • [8] Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis
    Jackson, Belinda
    De Cruz, Peter
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (11) : 1079 - 1100
  • [9] Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
    Solitano, Virginia
    D'Amico, Ferdinando
    Fiorino, Gionata
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 19
  • [10] Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis
    Ma, Christopher
    Jeyarajah, Jenny
    Guizzetti, Leonardo
    Parker, Claire E.
    Singh, Siddharth
    Dulai, Parambir S.
    D'Haens, Geert R.
    Sandborn, William J.
    Feagan, Brian G.
    Jairath, Vipul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 447 - +